MRI in ankylosing spondylitis

Current Opinion in Rheumatology

Volumn 21, Issue 4, 2009, Pages 313-317

  Maksymowych, Walter P ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Ankylosing spondylitis; Imaging; MRI; Sacroiliitis

Indexed keywords

ADALIMUMAB; C REACTIVE PROTEIN; ETANERCEPT; INFLIXIMAB; PLACEBO; TUMOR NECROSIS FACTOR ANTIBODY;

ANKYLOSING SPONDYLITIS; ANTIINFLAMMATORY ACTIVITY; CLINICAL TRIAL; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DIFFUSION WEIGHTED IMAGING; DISEASE DURATION; HUMAN; LOW BACK PAIN; MYELITIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT SELECTION; PREDICTIVE VALIDITY; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SACROILIAC JOINT; SACROILIITIS; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; SPONDYLITIS; SPONDYLOARTHROPATHY; TREATMENT DURATION; TREATMENT RESPONSE; WHOLE BODY MRI;

CLINICAL TRIALS AS TOPIC; HUMANS; MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT (HEALTH CARE); PREDICTIVE VALUE OF TESTS; PROGNOSIS; REPRODUCIBILITY OF RESULTS; SPINE; SPONDYLITIS, ANKYLOSING; TREATMENT OUTCOME;

EID: 67149138297     PISSN: 10408711     EISSN: None     Source Type: Journal    
DOI: 10.1097/BOR.0b013e32832af481     Document Type: Review

References (27)

1. Kim NR, Choi JY, Hong SH, et al. 'MR corner sign': value for predicting presence of ankylosing spondylitis. AJR Am J Roentgenol 2008; 191:124-128.
2. Akdeniz O, Alayli G, Tosun FC, et al. Early spondyloarthropathy: scintigraphic, biological, and clinical findings in MRI-positive patients. Clin Rheumatol 2008; 27:469-474.
3. Shankaranarayana S, Tan AL, Madden J, McGonagle D. Fat-suppression magnetic resonance imaging in the diagnosis of late-onset axial spondyloarthropathy. Ann Rheum Dis 2007; 66:1405-1406.
4. Hoenen-Clavert V, Rat AC, Loeuille D, et al. Inflammatory and structural evaluation in spondylarthritis: magnetic resonance imaging analysis of axial and peripheral involvement. J Rheumatol 2007; 34:762-768.
5. Lan HH, Chen DY, Chen CC, et al. Combination of transverse myelitis and arachnoiditis in cauda equina syndrome of long-standing ankylosing spondylitis: MRI features and its role in clinical management. Clin Rheumatol 2007; 26:1963-1967.
6. Arslanoglu A, Aygun N. Magnetic resonance imaging of cauda equina syndrome in long-standing ankylosing spondylitis. Australas Radiol 2007; 51:375-377.
7. Li EK, Griffith JF, Lee VW, et al. Short-term efficacy of combination methotrexate and infliximab in patients with ankylosing spondylitis: a clinical and magnetic resonance imaging correlation. Rheumatology 2008; 47:1358-1363.
8. Maksymowych WP, Gladman D, Rahman P, et al. The Canadian Rheumatology Association/Spondyloarthritis Research Consortium of Canada treatment recommendations for the management of spondylarthritis: a national multidisciplinary stakeholder project. J Rheumatol 2007; 34:2273-2284. An extensive consensus exercise reinforcing a major role of MRI in the selection of patients for anti-TNF therapy.
9. Pavy S, Dernis E, Lavie F, et al. Imaging for the diagnosis and follow-up of ankylosing spondylitis: development of recommendations for clinical practice based on published evidence and expert opinion. Joint Bone Spine 2007; 74:338-345.
10. Zochling J, Baraliakos X, Hermann KG, Braun J. Magnetic resonance imaging in ankylosing spondylitis. Curr Opin Rheumatol 2007; 19:346-352.
11. Maksymowych WP, Inman RD, Salonen D, et al. Spondylarthritis Research Consortium of Canada magnetic resonance imaging index for assessment of sacroiliac joint inflammation in ankylosing spondylitis. Arthritis Rheum 2005; 53:703-709.
12. Landewe RB, Hermann KG, van der Heijde DM, et al. Scoring sacroiliac joints by magnetic resonance imaging: a multiple-reader reliability experiment. J Rheumatol 2005; 32:2050-2055.
13. Lambert RGW, Salonen D, Rahman P, et al. Adalimumab significantly reduces both spinal and sacroiliac joint inflammation in patients with ankylosing spondylitis. Arthritis Rheum 2007; 56:4005-4014. Extensive validation exercise of the SPARCC scoring method for quantification of inflammation in the sacroiliac joints. Both reliability and discrimination are very high using this scoring method.
14. Braun J, Baraliakos X, Golder W, et al. Magnetic resonance imaging examinations of the spine in patients with ankylosing spondylitis, before and after successful therapy with infliximab: evaluation of a new scoring system. Arthritis Rheum 2003; 48:1126-1136.
15. Maksymowych WP, Inman RD, Salonen D, et al. Spondylarthritis Research Consortium of Canada magnetic resonance imaging index for assessment of spinal inflammation in ankylosing spondylitis. Arthritis Rheum 2005; 53:502-509.
16. Maksymowych WP, Dhillon SS, Park R, et al. Validation of the Spondylarthritis Research Consortium of Canada (SPARCC) MRI spinal inflammation index: is it necessary to score the entire spine? Arthritis Rheum 2007; 57:501-507.
17. Lukas C, Braun J, van der Heijde D, et al., ASAS/OMERACT MRI in AS Working Group. Scoring inflammatory activity of the spine by magnetic resonance imaging in ankylosing spondylitis: a multireader experiment. J Rheumatol 2007; 34:862-870. A multireader validation exercise demonstrating good reliability of scoring methods for spinal inflammation, particularly for the SPARCC method, and high discrimination for all methods when anti-TNF agents are assessed.
18. van der Heijde D, Landewe R, Hermann KG, et al., ASAS/OMERACT MRI in AS Working Group. Is there a preferred method for scoring activity of the spine by magnetic resonance imaging in ankylosing spondylitis? J Rheumatol 2007; 34:871-873.
19. Bennett AN, McGonagle D, O'Connor P, et al. Severity of baseline magnetic resonance imaging-evident sacroiliitis and HLA-B27 status in early inflammatory back pain predict radiographically evident ankylosing spondylitis at eight years. Arthritis Rheum 2008; 58:3413-3418. Long-term follow-up study of up to 8 years demonstrating that the severity of bone edema on sacroiliac joint MRI has predictive validity for radiographic sacroiliitis in patients with IBP but normal baseline radiograph.
20. Baraliakos X, Listing J, Rudwaleit M, et al. The relationship between inflammation and new bone formation in patients with ankylosing spondylitis. Arthritis Res Ther 2008; 10:R104. A study of the prognostic validity of inflammatory vertebral lesions on baseline MRI demonstrating an association with new syndesmophyte formation on radiography.
21. Maksymowych WP, Chiowchanwisawakit P, Clare T, et al. Inflammatory lesions of the spine on magnetic resonance imaging predict the development of new syndesmophytes in ankylosing spondylitis: evidence of a relationship between inflammation and new bone formation. Arthritis Rheum 2009; 60:93-102. A study of the prognostic validity of inflammatory vertebral lesions on both baseline and follow-up MRI in both a clinical trial and an observational cohort of AS patients receiving anti-TNF therapy. This demonstrated not only an association between vertebral lesions and new syndesmophytes on radiography but also an association between lesions that resolve following treatment and new syndesmophytes. The authors propose the hypothesis that TNF may be important in a well established inflammatory lesion in preventing new bone formation driven by bone growth factors.
22. Rudwaleit M, Schwarzlose S, Hilgert ES, et al. MRI in predicting a major clinical response to antitumour necrosis factor treatment in ankylosing spondylitis. Ann Rheum Dis 2008; 67:1276-1281. The presence of inflammatory lesions on MRI has predictive capacity for a major clinical response, particularly when combined with disease duration and CRP.
23. Gaspersic N, Sersa I, Jevtic V, et al. Monitoring ankylosing spondylitis therapy by dynamic contrast-enhanced and diffusion-weighted magnetic resonance imaging. Skeletal Radiol 2008; 37:123-131.
24. Bozgeyik Z, Ozgocmen S, Kocakoc E. Role of diffusion-weighted MRI in the detection of early active sacroiliitis. AJR Am J Roentgenol 2008; 191:980-986.
25. Appel H, Hermann KG, Althoff CE, et al. Whole-body magnetic resonance imaging evaluation of widespread inflammatory lesions in a patient with ankylosing spondylitis before and after 1 year of treatment with infliximab. J Rheumatol 2007; 34:2497-2498.
26. Althoff CE, Appel H, Rudwaleit M, et al. Whole-body MRI as a new screening tool for detecting axial and peripheral manifestations of spondylarthritis. Ann Rheum Dis 2007; 66:983-985.
27. Weber U, Pfirrmann CW, Kissling RO, et al. Whole body MR imaging in ankylosing spondylitis: a descriptive pilot study in patients with suspected early and active confirmed ankylosing spondylitis. BMC Musculoskelet Disord 2007; 8:20-32.